The Role of Personalized Exercise Protocols Informed by Gut Microbiome Analysis in Improving Metabolic Syndrome Outcomes: A Randomized Controlled Trial
Abstract
Metabolic syndrome (MetS) is increasingly becoming a global health concern. It is defined by obesity, insulin resistance, high blood pressure, and high triglyceride levels (Saklayen, 2018). Regarding the microbial community, recent discoveries have shown that the gut can influence the metabolic status. However, there is still an open question of how one should design the exercise program with the gut microbiota profiling information. This research seeks to establish the impact of a customized exercise program on metabolic syndrome based on the subjects' gut microbiome. The study employed a randomized controlled trial (RCT) design whereby ten participants diagnosed with MetS underwent gut microbiome assessment via 16S rRNA gene sequencing, a polymerase chain reaction (PCR)-based method that identifies microbial diversity and composition (Dugas, et al., 2018). They were given specific exercises that would directly address their excess of gut microbiota and abnormal metabolic profiles. To evaluate the efficacy of these individualized interventions at various periods up to the twelfth week, biochemical parameters with implications in a clinical context, including fasting blood glucose, lipid profile, Body Mass Index (BMI), and biomarkers of inflammation, were quantified in the study. This metabolic improvement in the patients was most significant for those who had taken a microbiome-based exercise intervention compared to those on regular exercise. There were enhancements in the…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.